Nuclear factor-κB inhibition in sepsis: Steroids versus specific nuclear factor-κB inhibitors?

Critical Care Medicine

Volumn 30, Issue 10, 2002, Pages 2393-2394

  Marik, Paul E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain inhibitor I; Corticosteroids; Cyclooxygenase 2; Multiorgan dysfunction syndrome; Murine model; Nitric oxide synthase; Nuclear factor B; Nuclear factor B inhibition; Sepsis; Systemic inflammatory response syndrome; Zymosan

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; CALPASTATIN; CELL ADHESION MOLECULE; CYCLOSPORIN A; CYSTEINE PROTEINASE INHIBITOR; ERYTHROMYCIN; GLUCOCORTICOID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; METHOTREXATE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CALPAIN; CALPAIN INHIBITORS; GLYCOPROTEIN;

CYTOKINE PRODUCTION; EDITORIAL; ENZYME ACTIVATION; INFLAMMATION; INHIBITION KINETICS; IONIZING RADIATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPSIS; ANIMAL; DRUG ANTAGONISM; METABOLISM; MULTIPLE ORGAN FAILURE; NOTE; RAT; SEPTIC SHOCK;

ANIMALS; CALPAIN; GLUCOCORTICOIDS; GLYCOPROTEINS; MULTIPLE ORGAN FAILURE; NF-KAPPA B; RATS; SHOCK, SEPTIC;

EID: 0036771791     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200210000-00042     Document Type: Editorial

References (29)

1. Christman JW, Lancaster LH, Blackwell TS: Nuclear factor kappa B: A pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 1998; 24:1131-1138
2. Bohrer H, Qiu F, Zimmermann T, et al: Role of NFkappaB in the mortality of sepsis. J Clin Invest 1997; 100:972-985
3. Natanson C, Esposito CJ, Banks SM: The sirens' songs of confirmatory sepsis trials: Selection bias and sampling error. Crit Care Med 1998; 26:1927-1931
4. Marik PE, Varon J: Sepsis: State of the art. Dis Mon 2001; 47:463-532
5. Blanchard JA, Barve S, Joshi-Barve S, et al: Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 2001; 46:2768-2772
6. Blackwell TS, Blackwell TR, Holden EP, et al: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157:1630-1637
7. Stevenson MA, Zhao MJ, Asea A, et al: Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. J Immunol 1999; 163:5608-5616
8. Majumdar S, Aggarwal BB: Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J Immunol 2001; 167:2911-2920
9. Aljada A, Ghanim H, Assian E, et al: Increased IkappaB expression and diminished nuclear NF-kappaB in human mononuclear cells following hydrocortisone injection. J Clin Endocrinol Metab 1999;84:3386-3389
10. Aoki Y, Kao PN: Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrobial Agents Chemother 1999; 43:2678-2684
11. Schlaak JF, Barreiros AP, Pettersson S, et al: Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice. Scand J Immunol 2001; 54:396-403
12. Wang KK, Yuen PW: Development and therapeutic potential of calpain inhibitors. Adv Pharmacol 1997; 37:117-152
13. Schreck R, Meier B, Mannel DN, et al: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175:1181-1194
14. Kim CH, Kim JH, Moon SJ, et al: Biphasic effects of dithiocarbamates on the activity of nuclear factor-kappaB. Eur J Pharmacol 2000; 392:133-136
15. Meiners S, Laule M, Rother W, et al: Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 2002; 105:483-489
16. Cuzzocrea S, Chatterjee PK, Mazzon E, et al: Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat. Crit Care Med 2002; 30:2284-2294
17. Ruetten H, Thiemermann C: Effect of calpain inhibitor 1, an inhibitor of the proteolysis of Ikappa beta on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 1997;121:695-704
18. Barnes PJ, Adcock I: Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 1993; 14:436-441
19. Barnes PJ, Karin M: Nuclear factor-kB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071
20. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1994; 91:752-756
21. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
22. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
23. Annane D: Effects of the combination of hydrocortisone-Fludro-cortisone on mortality in septic shock. Abstr Crit Care Med 2000; 28(Suppl):A46
24. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med, In Press
25. Zaloga GP, Marik P: Hypothalamic-pituitaryadrenal insufficiency. Crit Care Clin 2001; 17:25-42
26. Sakaue M, Hoffman BB: Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88:385-389
27. Collins S, Caron MG, Lefkowitz RJ: Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263: 9067-9070
28. van Leeuwen HJ, van der BT, van Asbeck BS, et al: Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock. Crit Care Med 2001; 29: 1074-1077
29. Frode-Saleh TS, Calixto JB: Synergistic antiinflammatory effect of NF-kappaB inhibitors and steroidal or non steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice. Inflamm Res 2000; 49:330-337